Table 2 Clinical characteristics of asthmatic children before, 3 and 6 months after inhaled corticosteroid therapy
Parameters | Before | 3 months | 6 months | Test p |
|---|---|---|---|---|
PEF (%) (mean±SD) | ANOVA | |||
mPA | 81.2±17.3 | 90.6±23.6 | 99.2±18.4 | p < 0.05* |
MPA | 75.6±15.3 | 79.3±16.8 | 86.3±18.3 | p < 0.05* |
SPA | 65.6±12.0 | 72.8±17.0 | 77.9±19.8 | p > 0.05 |
BMI (Kg/m2) (mean±SD) | ||||
mPA | 51.9±34.3 | 45.2±32.2 | 43.4±37.5 | Kruskal-Wallis p>0.05 |
MPA | 47.4±31.2 | 50.5±31.5 | 50.0±30.5 | |
SPA | 63.7±32.5 | 61.8±29.6 | 63.2±29.5 | |
ACT n (%) | ||||
mPA | ||||
≥25 | 0/23 (0%) | 1/23 (4.3%) | 4/22 (18.2%) | Chi-square |
20-24** | 11/23 (47.8%) | 19/23 (82.6%) | 16/22 (72.7%) | p<0.05 |
<20*** | 12/23 (52.2%) | 3/23 (13.0%) | 2/22 (9.1%) | |
MPA | ||||
≥25 | 0/20 0%) | 1/20 (5%) | 3/20 (15%) | Chi-square |
20-24** | 2/20 (10%) | 7/20 (35%) | 10/20 (50.0%) | p<0.05 |
<20*** | 18/20 (90%) | 12/20 (60%) | 7/20 (35.0%) | |
SPA | ||||
≥25 | 0/14 (0%) | 0/14 (0%) | 0/14 (0%) | Chi-square |
20-24 | 2/14 (14.3%) | 3/14 (21.4%) | 4/14 (28.6%) | p>0.05 |
<20 | 12/14 (85.7%) | 11/14 (78.57%) | 10/14 (71.4%) |